Many epidemiological studies suggest an association between antibiotic exposure and the development of inflammatory bowel disease [IBD]. However, the majority of these studies are observational and still the question remains, “Does the specific antibiotic administration regimen play a role in the development of colitis?” This study aimed to compare the possible effects of continuous and intermittent antibiotic exposure on the development of colitis using a colitis-susceptible IL-10 knockout [IL-10–/–] mouse model
In inflammatory bowel diseases (IBD), it is known that besides genetic and environmental factors (e....
AIM: To investigate the effect of Clostridium difficile (C. difficile) infection in an interleukin 1...
Background: Probiotics are used in the therapy of inflammatory bowel disease. This study aimed to de...
The constellation of human inflammatory bowel disease (IBD) includes ulcerative colitis and Crohn's ...
Background and aims: Multiple rodent models implicate resident intestinal bacteria in the pathogenes...
International audienceBackground: There is increasing evidence that the intestinal microbiota plays ...
Mutations that increase susceptibility to inflammatory bowel disease (IBD) have been identified in a...
Mice with targeted deletion of the gene for interleukin-10 (IL-10) spontaneously develop enterocolit...
Human infections with the food-borne enteropathogens Campylobacter are progressively rising. Recent ...
IDI&CA_IPL/2019/COLITiS_ESTeSLFCT_UIDB/05608/2020. FCT_UIDP/05608/2020.Background: Inflammatory bowe...
Background: Prophylactic efficacy against colitis following lactobacillus consumption in interleukin...
The aim of this study was to establish a bacteria-induced mouse model of human IBD applicable for in...
We evaluated whether a simplified human microbiota consortium (SIHUMI) induces colitis in germfree (...
Cytokines play a role in the inflammatory process in colitis and may have therapeutic potential. Int...
Background: Inflammatory bowel disease (IBD) is a world healthcare problem. In order to evaluate the...
In inflammatory bowel diseases (IBD), it is known that besides genetic and environmental factors (e....
AIM: To investigate the effect of Clostridium difficile (C. difficile) infection in an interleukin 1...
Background: Probiotics are used in the therapy of inflammatory bowel disease. This study aimed to de...
The constellation of human inflammatory bowel disease (IBD) includes ulcerative colitis and Crohn's ...
Background and aims: Multiple rodent models implicate resident intestinal bacteria in the pathogenes...
International audienceBackground: There is increasing evidence that the intestinal microbiota plays ...
Mutations that increase susceptibility to inflammatory bowel disease (IBD) have been identified in a...
Mice with targeted deletion of the gene for interleukin-10 (IL-10) spontaneously develop enterocolit...
Human infections with the food-borne enteropathogens Campylobacter are progressively rising. Recent ...
IDI&CA_IPL/2019/COLITiS_ESTeSLFCT_UIDB/05608/2020. FCT_UIDP/05608/2020.Background: Inflammatory bowe...
Background: Prophylactic efficacy against colitis following lactobacillus consumption in interleukin...
The aim of this study was to establish a bacteria-induced mouse model of human IBD applicable for in...
We evaluated whether a simplified human microbiota consortium (SIHUMI) induces colitis in germfree (...
Cytokines play a role in the inflammatory process in colitis and may have therapeutic potential. Int...
Background: Inflammatory bowel disease (IBD) is a world healthcare problem. In order to evaluate the...
In inflammatory bowel diseases (IBD), it is known that besides genetic and environmental factors (e....
AIM: To investigate the effect of Clostridium difficile (C. difficile) infection in an interleukin 1...
Background: Probiotics are used in the therapy of inflammatory bowel disease. This study aimed to de...